NeOnc Technologies Holdings is trading at $3.47, up 5.15%, with broader technology-market strength potentially supportive. - The Nasdaq Composite is up 0.87% in the supplied market context. - No distinct September 30 company announcement explaining the move surfaced. - Coverage highlighted the previously announced November 17 FDA meeting for NEO212. Announced September 28, the meeting is scheduled and does not represent FDA endorsement; it is not a new catalyst today.